Drug Diaries

summary In this conversation, Kaushik Trivedi and Philip Morsky delve into the critical issue of medication non-adherence, exploring its causes, consequences, and innovative solutions. They discuss the Morisky Medication Adherence Scale, the importance of building trust in patient-provider relationships, and the role of technology in improving adherence rates. The conversation highlights the finan...

Learn the shocking truth about Cholangiocarcinoma in this eye-opening video. Join us as we discuss the patient journey, clinical trials, and the resilience of those affected by this rare cancer. #Cholangiocarcinoma #canceradvocacy #rarecancers summary This conversation explores the journey of Melinda Bachini, a cholangiocarcinoma survivor, who shares her experiences from diagnosis to advocacy. The...

summary This conversation explores the recent resurgence of pharmaceutical companies in the mental health sector, focusing on innovative treatments like Kar-XT for schizophrenia. It discusses the complexities of mental illness, the challenges in drug development, and the strategic motivations behind these industry shifts. takeaways Pharmaceutical giants are investing heavily in mental health. Kar-...

The conversation delves into the complexities of sleeping sickness, a neglected tropical disease affecting vulnerable populations in Africa. Experts Dr. Olaf Valverde from DNDi and Dr. Philippe Neau from Sanofi discuss the evolution of treatment, the significance of collaboration between organizations, and the innovative drugs being developed to combat the disease. They emphasize the importance of...

summary In this conversation, Dr. Manuel Corpas discusses the future of genomics, emphasizing the importance of diversity and health equity in genomic research. He highlights the challenges of precision medicine, which often excludes underrepresented populations, and shares personal experiences that shaped his mission to bridge health disparities. The discussion also addresses the impact of bias i...

summary In this conversation, Kaushik Trivedi and Dr. Paul Agapal explore the transformative role of data and AI in the future of medicine. They discuss how algorithms are reshaping drug discovery, the importance of personalized medicine, and the ethical considerations of AI in healthcare. Dr. Agapal shares insights from his journey in biotech, emphasizing the need for adaptability and the signifi...

In this conversation, Kaushik Trivedi and Dr. Scott Russo delve into the pressing issues of mental health, exploring the impact of stress, trauma, and biological factors on our well-being. They discuss the alarming statistics surrounding suicide and mental health disorders, the dual nature of stress, and how chronic stress can reshape our brains. The conversation also highlights the role of inflam...

CAPTIONS ARE AUTOGENERATED Discover how causal AI could revolutionize the healthcare industry forever. Learn about the impact of generative AI in data analysis and machine learning for healthcare and pharmaceuticals. summary In this conversation, Kaushik Trivedi, John Moran, and Ben Phillips delve into the transformative potential of Causal AI in the pharmaceutical industry. They discuss the diffe...

summary In this enlightening conversation, Annette Zoe Powers, Senior Vice President at Bristol Myers Squibb, shares her journey through the healthcare industry, emphasizing the importance of leadership that balances empathy with strategy. She discusses the evolving landscape of market access, the challenges patients face in accessing therapies, and the role of digital health and AI in shaping the...

Type 1 Diabetes: A Father's Pursuit to Inspire Change || Drug Diaries ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ ➖ 🌟🔰===================================🌟🔰 In this video: In this episode of Drug Diaries, Kaushik Trivedi speaks with Simon Ruben, a filmmaker and father of a child with type 1 diabetes. They discuss the emotional and psychological challenges faced by families dealing with...

keywords healthcare technology, innovation, digital transformation, patient education, AI, healthcare access, regulatory challenges, generative AI, electronic health records, healthcare outcomes summary In this episode of Drug Diaries, host Kaushik Trivedi interviews Engers Fernandez, an executive technology leader and VP of Innovation at Ochin Inc. They discuss Engers' journey in healthcare techn...

Summary In this conversation, Professor Olshansky discusses the evolving science of aging and longevity, emphasizing the importance of exercise, the concept of the longevity dividend, and the need to focus on healthspan rather than lifespan. He shares insights from his extensive research on human aging, the economic implications of an aging population, and the potential of geroprotectors to enhanc...

Discover the groundbreaking AI aging breakthrough by Raghav Sehgal! This technology will revolutionize longevity and health - a game-changer in the world of computational biology and venture capital. keywords artificial intelligence, aging, longevity, health technology, biomarkers, DNA methylation, venture capital, ethical considerations, personalized medicine, computational biology summary In thi...

summary In this episode of Drug Diaries, we hear from Conchi Biurrun Martinez, a cancer survivor who shares her personal journey through diagnosis, treatment, and recovery. Conchi discusses the emotional and physical challenges she faced, the importance of support systems, and the need for patient empowerment through information. She emphasizes the evolution of cancer treatments and the significan...

Discover Tim Wright's shocking insights on digital healthcare innovation, healthcare startups, and regulatory challenges. Find out how to navigate the digital health landscape and succeed as a strategic partner in the healthcare industry. summary In this episode of Drug Diaries, Kaushik Trivedi and Tim Wright discuss the complexities and exciting opportunities in healthcare innovation. They explor...

summary In this episode of Drug Diaries, host Kaushik Trivedi speaks with Amir Hefni, CEO of Resolution Therapeutics, about groundbreaking innovations in treating chronic liver disease through macrophage cell therapy. They discuss the recent funding success, the science behind the therapy, the challenges of clinical trials, and the importance of leadership and teamwork in biotech. Amir shares insi...

Digital disruption in pharma has changed my perspective on healthcare forever! Learn how AI, data analytics, and omni-channel marketing are transforming the pharmaceutical industry. #DigitalTransformation #Healthcare #Pharmaceuticals #DataAnalytics #ai Summary In this episode of Drug Diaries, host Kaushik Trivedi engages with Alyssa Fenoglio, the global head of digital commercial at Teva, to explo...

Join us on a global health mission to eliminate sleeping sickness, a neglected tropical disease transmitted by the tsetse fly. Learn how Sanofi is working to combat this disease and improve public health worldwide. takeaways Sleeping sickness is a curable disease that affects remote communities. Neglected tropical diseases often receive limited funding and attention. Sanofi is committed to elimina...

Join Scott Fulton as he shares his proven strategies for the future of aging, covering lifespan, wellness, health, and more. Don't miss out on this insightful discussion on aging in place and smart housing options! summary In this episode of Drug Diaries, host Kaushik Trivedi and guest Scott Fulton explore the concept of lifespan housing and its impact on health, wellness, and longevity. They disc...

cancer research, biomarkers, immuno-oncology, drug development, bioinformatics, targeted therapies, clinical trials, interdisciplinary collaboration, healthcare innovation, GSK summary In this episode of Drug Diaries, host Kaushik Trivedi engages with Daniel Lowther, Director of Clinical Biomarkers at GSK, to explore groundbreaking innovations in cancer research, particularly focusing on biomarker...

summary Rakesh Vashisht, Global Head of Customer Facing Execution Excellence at Boehringer Ingelheim, shares his 30-year journey in the pharmaceutical industry and discusses the evolving landscape of customer engagement. He emphasizes the importance of wisdom, earned through experience, and the need for passion, hard work, and a growth mindset in the industry. Rakesh highlights the challenges of i...

summary Dr. Carly Schissel, a powerhouse in the world of organic chemistry, discusses her role in designing molecules for drug discovery and development. She explains the importance of designing drugs that work in the right way with the right target and with the fewest side effects. Dr. Schissel shares her research on the chemical biology of peptides and the breakthroughs she has made in peptide d...

In this episode of Drug Diaries, Dr. Bede Portz discusses the field of condensate biology and its potential impact on drug discovery. Condensates are membrane-less structures in cells that provide an intermediate level of organization between randomness and membrane-encompassed organelles. By studying condensates, researchers can gain new insights into cellular processes and develop innovative app...

In this episode of Drug Diaries, Dr. Bede Portz discusses the field of condensate biology and its potential impact on drug discovery. Condensates are membrane-less structures in cells that provide an intermediate level of organization between randomness and membrane-encompassed organelles. By studying condensates, researchers can gain new insights into cellular processes and develop innovative app...

Today's episode of Drug Diaries focuses on Duchenne Muscular Dystrophy (DMD) and the groundbreaking research conducted by Somesh Mohapatra and his team. They have used artificial intelligence and experimental chemistry to develop new sequences for gene therapy in DMD. The research involved experimental screening, machine learning, interpretability, and optimization. The process took approximately...